<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>GOT - Moria - Alchimia</title>
	<atom:link href="https://alchimiasrl.com/information/ophthalmic-surgery/ophthalmic-gases/got/feed/" rel="self" type="application/rss+xml" />
	<link>https://alchimiasrl.com/information/ophthalmic-surgery/ophthalmic-gases/got/</link>
	<description>Your ideas, our solutions</description>
	<lastBuildDate>Mon, 29 Apr 2019 10:12:58 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://alchimiasrl.com/wp-content/uploads/2020/03/cropped-Icon-per-sito-32x32.jpg</url>
	<title>GOT - Moria - Alchimia</title>
	<link>https://alchimiasrl.com/information/ophthalmic-surgery/ophthalmic-gases/got/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>25-gauge vitrectomy and gas for the management of rhegmatogenous retinal detachment</title>
		<link>https://alchimiasrl.com/25-gauge-vitrectomy-and-gas-for-the-management-of-rhegmatogenous-retinal-detachment/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Thu, 21 Jun 2018 09:45:46 +0000</pubDate>
				<category><![CDATA[GOT]]></category>
		<category><![CDATA[Ophthalmic gases]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=15492</guid>

					<description><![CDATA[<p>Year: 2018 Authors: Veitha M.; Stranaka Z.; Pencaka M.; Vranovab J.; Studenya P.     Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (Biomed Paper) doi: 10.5507/bp.2018.034 Online version This is a: Publication   Aims: To evaluate the anatomical and functional results in patients with rhegmatogenous retinal detachment  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/25-gauge-vitrectomy-and-gas-for-the-management-of-rhegmatogenous-retinal-detachment/">25-gauge vitrectomy and gas for the management of rhegmatogenous retinal detachment</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-image-element fusion-image-align-center in-legacy-container" style="text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);"><div class="imageframe-align-center"><span class=" fusion-imageframe imageframe-none imageframe-1 hover-type-none"><img decoding="async" width="200" height="200" title="Biomedical papers" src="https://alchimiasrl.com/wp-content/uploads/2019/04/Biomedical-papers.jpg" alt class="img-responsive wp-image-15493" srcset="https://alchimiasrl.com/wp-content/uploads/2019/04/Biomedical-papers-66x66.jpg 66w, https://alchimiasrl.com/wp-content/uploads/2019/04/Biomedical-papers-100x100.jpg 100w, https://alchimiasrl.com/wp-content/uploads/2019/04/Biomedical-papers-150x150.jpg 150w, https://alchimiasrl.com/wp-content/uploads/2019/04/Biomedical-papers.jpg 200w" sizes="(max-width: 200px) 100vw, 200px" /></span></div></div><div class="fusion-text fusion-text-1"><p><strong>Year: </strong>2018</p>
<p><strong>Authors</strong>: Veitha M.; Stranaka Z.; Pencaka M.; Vranovab J.; Studenya P.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:0px;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-2"><p>Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia (Biomed Paper)<br />
doi: 10.5507/bp.2018.034<br />
<a href="https://www.researchgate.net/publication/326151044_25-gauge_vitrectomy_and_gas_for_the_management_of_rhegmatogenous_retinal_detachment">Online version</a></p>
</div><div class="fusion-text fusion-text-3"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-4"><p><strong>Aims:</strong> To evaluate the anatomical and functional results in patients with rhegmatogenous retinal detachment (RRD) who underwent 25-gauge pars plana vitrectomy (PPV) with gas tamponade.</p>
<p><strong>Materials and Methods:</strong> A retrospective evaluation of 126 eyes of 126 patients (79 men, 47 women) with RRD who underwent 25-gauge PPV with gas tamponade (13% C3F8 in 87 eyes, 20% SF6 in 39 eyes). 113 patients (89.7%), were operated on under local anaesthesia, 13 patients (10.3%) under general anaesthesia. Macula was detached in 85 eyes (67.5%). 53 eyes had pseudophakic RRD, 73 eyes were phakic. Anatomical success of the primary intervention, change in best corrected visual acuity (BCVA) and incidence of complications were assessed. An average follow-up period is 7.2 months (6-15).</p>
<p><strong>Results:</strong> With single operation, retinal attachment was achieved in 125 eyes (99.2%); the final anatomical success was 100%. The initial mean BCVA was 0.89 logMar (2.00 to 0.00); at the end of the follow-up period, it improved to 0.23logMAR (1.00 to -0.10), P &lt; 0,0001. During the first post-intervention day, hypotony of the eye below 10 mmHg was observed in 1 patient (0.8%); on the contrary, intraocular pressure was temporarily increased to 25 mmHg and more in 36 patients (28.6%).</p>
<p><strong>Conclusion:</strong> The surgical treatment of RRD using 25-gauge PPV with expansive gas tamponade renders excellent anatomical results and improvement in BCVA. The incidence of complications and necessity of sclerotomy suturing are low.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/25-gauge-vitrectomy-and-gas-for-the-management-of-rhegmatogenous-retinal-detachment/">25-gauge vitrectomy and gas for the management of rhegmatogenous retinal detachment</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thirteen-Year Vitreoretinal Surgical Outcomes of 5,097 Cases from a Tertiary Referral Center in Turkey</title>
		<link>https://alchimiasrl.com/thirteen-year-vitreoretinal-surgical-outcomes-of-5097-cases-from-a-tertiary-referral-center-in-turkey/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Mon, 28 Oct 2013 15:48:20 +0000</pubDate>
				<category><![CDATA[GOT]]></category>
		<category><![CDATA[Ophthalmic gases]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=12752</guid>

					<description><![CDATA[<p>Year: 2013 Authors: Teke M.Y.; Balikogly-Yilmaz M.; Yuksekkaya P.; Citirik M.; Elgin U.; Ozdal P.; Yenigun S.; Sen E.; Ozturk F.     Opthalmologica 230: 186-94, 2013 Online version  This is a: Publication   Abstract: A 13-year retrospective chart review of 5,097 consecutive cases that underwent pars plana vitrectomy (PPV), and retinal  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/thirteen-year-vitreoretinal-surgical-outcomes-of-5097-cases-from-a-tertiary-referral-center-in-turkey/">Thirteen-Year Vitreoretinal Surgical Outcomes of 5,097 Cases from a Tertiary Referral Center in Turkey</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-5"><p><strong>Year: </strong>2013</p>
<p><strong>Authors</strong>: Teke M.Y.; Balikogly-Yilmaz M.; Yuksekkaya P.; Citirik M.; Elgin U.; Ozdal P.; Yenigun S.; Sen E.; Ozturk F.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:0px;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-6"><p>Opthalmologica 230: 186-94, 2013<br />
<a href="http://www.ncbi.nlm.nih.gov/pubmed/24080789">Online version</a></p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-7"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-8"><p><strong>Abstract: </strong>A 13-year retrospective chart review of 5,097 consecutive cases that underwent pars plana vitrectomy (PPV), and retinal tamponade with GOT SF6 multi or GOT C3F8 (AL.CHI.MI.A. S.r.l.) according to the specific case, in a tertiary referral center in Turkey was performed. Age at onset, sex, laterality, associated systemic diseases, pre- and postoperative visual acuities (VA), indications, type of surgery and outcome of surgery were analyzed. The most common indications for vitreoretinal surgery (VRS) were rhegmatogenous retinal detachment (n = 1,802, 35.4%) and proliferative diabetic retinopathy (n 0 1,505, 29.5%). The most common vitreoretinal technique combinations performed were PPV with encircling endolaser (EL) and phacoemulsification with intraocular lens implantation (33,0%)., PPV with encircling EL (30.4%), and only PPV (7.0%). A statistically significant increase in the mean VA was noted at the first- (1.16 ± 0.44 logarithm of the minimum angle of resolution, logMAR) and sixth-month (1.06 ± 0.61 logMAR) visits when compared to the preoperative VA (1.77 ± 0.58 logMAR; p &lt;  0.001). Comparisons in the top surgical indications, techniques and outcomes for vitrectomy between the countries could be important for the development of subspecialization in VRS.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/thirteen-year-vitreoretinal-surgical-outcomes-of-5097-cases-from-a-tertiary-referral-center-in-turkey/">Thirteen-Year Vitreoretinal Surgical Outcomes of 5,097 Cases from a Tertiary Referral Center in Turkey</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment</title>
		<link>https://alchimiasrl.com/primary-23-gauge-vitreoretinal-surgery-for-rhegmatogenous-retinal-detachment/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Mon, 28 May 2012 15:47:11 +0000</pubDate>
				<category><![CDATA[GOT]]></category>
		<category><![CDATA[Ophthalmic gases]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=12750</guid>

					<description><![CDATA[<p>Year: 2012 Authors: Yanyali A.; Celik G.; Dincyildiz A.; Horozoglu F.; Nohutcu A.F.     Int J Ophthalmol. 5(2): 226–230, 2012 Online version  This is a: Publication   Abstract: We evaluated 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/primary-23-gauge-vitreoretinal-surgery-for-rhegmatogenous-retinal-detachment/">Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-9"><p><strong>Year: </strong>2012</p>
<p><strong>Authors</strong>: Yanyali A.; Celik G.; Dincyildiz A.; Horozoglu F.; Nohutcu A.F.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:0px;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-10"><p>Int J Ophthalmol. 5(2): 226–230, 2012<br />
<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359044/">Online version</a></p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-11"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-12"><p><strong>Abstract: </strong>We evaluated 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July 2009.</p>
<p>The internal tamponades used in the treatment of RRD included GOT SF6 multi and GOT C3F8 multi (Alchimia, Ponte S. Nicolò, Italy).<br />
Mean follow-up time was 8.9 ± 7.7 months (1-28 months). Retinal reattachment was achieved with a single operation in 47 (95.9%) of 49 eyes.</p>
<p>Mean logMAR visual acuity was 2.01 ± 0.47 preoperatively and 1.3 ± 0.5 postoperatively. Mean preoperative intraocular pressure (IOP) was 14.1 ± 2.8 mmHg.</p>
<p>Mean postoperative IOP was 12.3 ± 3.6 mmHg at 1 day, 13.1 ± 2.1 mmHg at 1 week, 14.3 ± 2.2 mmHg at 1 month. Iatrogenic peripheral retinal break was observed in 1 eye (2.0% ) intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required convertion of surgery to 20-G vitrectomy.</p>
<p>Primary 23-G TSV system was observed to be effective and safe in the treatment of RRD.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/primary-23-gauge-vitreoretinal-surgery-for-rhegmatogenous-retinal-detachment/">Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
